Drug Trial Radar · NCT01270971
Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
Last checked: Nov 19, 2026Latest source record: Feb 22, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
594
Actual
Start
Dec 1, 2010
Primary completion
Nov 30, 2012
Study completion Jan 8, 2013
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jan 6, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.
Conditions
- Onychomycosis of Toenails
Interventions
AN2690 Topical Solution, 5%Drug
AN2690 Topical Solution, 5%, applied once daily for 48 weeks
Solution VehicleDrug
AN2690 Topical Solution, Vehicle, applied once daily for 48 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete Cure (Completely Clear Nail and Negative Mycology) of Target Great Toenail at Week 52Time frame: Week 52
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
Investigational Site
Tucson, Arizona
Investigational Site
Hot Springs, Arkansas
Investigational Site
Burbank, California
Investigational Site
Los Angeles, California
Investigational Site
San Francisco, California
Investigational Site
Denver, Colorado
Investigational Site
Orange Park, Florida
Investigational Site
Boise, Idaho
Investigational Site
Evansville, Indiana
Investigational Site
Overland Park, Kansas
Investigational Site
Baltimore, Maryland
Investigational Site
Fridley, Minnesota
Investigational Site
Omaha, Nebraska
Investigational Site
New York, New York
Investigational Site
New York, New York
Investigational Site
Rochester, New York
Investigational Site
Winston-Salem, North Carolina
Investigational Site
Cincinnati, Ohio
Investigational Site
South Euclid, Ohio
Investigational Site
Portland, Oregon
Investigational Site
Providence, Rhode Island
Investigational Site
Germantown, Tennessee
Investigational Site
Austin, Texas
Investigational Site
College Station, Texas
Investigational Site
San Antonio, Texas
Investigational Site
Lynchburg, Virginia
Investigational Site
Spokane, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.